Form 8-K - Current report:
SEC Accession No. 0001493152-24-035390
Filing Date
2024-09-09
Accepted
2024-09-09 07:30:14
Documents
29
Period of Report
2024-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49639
2 ex99-1.htm EX-99.1 19173
3 ex99-1_001.jpg GRAPHIC 514084
4 ex99-1_002.jpg GRAPHIC 529626
5 ex99-1_003.jpg GRAPHIC 272709
6 ex99-1_004.jpg GRAPHIC 260571
7 ex99-1_005.jpg GRAPHIC 164592
8 ex99-1_006.jpg GRAPHIC 205271
9 ex99-1_007.jpg GRAPHIC 183400
10 ex99-1_008.jpg GRAPHIC 280926
11 ex99-1_009.jpg GRAPHIC 216735
12 ex99-1_010.jpg GRAPHIC 175196
13 ex99-1_011.jpg GRAPHIC 240269
14 ex99-1_012.jpg GRAPHIC 328470
15 ex99-1_013.jpg GRAPHIC 306382
16 ex99-1_014.jpg GRAPHIC 176846
  Complete submission text file 0001493152-24-035390.txt   5622948

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE hrow-20240909.xsd EX-101.SCH 3944
18 XBRL DEFINITION FILE hrow-20240909_def.xml EX-101.DEF 32001
19 XBRL LABEL FILE hrow-20240909_lab.xml EX-101.LAB 38304
20 XBRL PRESENTATION FILE hrow-20240909_pre.xml EX-101.PRE 28608
31 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7996
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 241285859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)